RT Journal Article
SR Electronic
T1 COVID-19 in children in NSW, Australia, during the 2021 Delta outbreak: Severity and Disease spectrum
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.27.21268348
DO 10.1101/2021.12.27.21268348
A1 Williams, Phoebe
A1 Koirala, Archana
A1 Saravanos, Gemma
A1 Lopez, Laura
A1 Glover, Catherine
A1 Sharma, Ketaki
A1 Williams, Tracey
A1 Carey, Emma
A1 Shaw, Nadine
A1 Dickins, Emma
A1 Sitaram, Neela
A1 Ging, Joanne
A1 Bray, Paula
A1 Crawford, Nigel
A1 McMullan, Brendan
A1 Macartney, Kristine
A1 Wood, Nicholas
A1 Fulton, Beth
A1 Lau, Christine
A1 Britton, Philip N
YR 2021
UL http://medrxiv.org/content/early/2021/12/29/2021.12.27.21268348.abstract
AB Objective(s) To describe the severity and clinical spectrum of SARS-CoV-2 infection in Australian children during the 2021 Delta outbreak.Design, Setting & Participants A prospective cohort study of children <16 years with a positive SARS-CoV-2 nucleic acid test cared for by the Sydney Children’s Hospital Network (SCHN) virtual and inpatient medical teams between 1 June – 31 October 2021.Main outcome measures Demographic and clinical data from all admitted patients and a random sample of outpatients managed under the SCHN virtual care team were analysed to identify risk factors for admission to hospital.Results There were 17,474 SARS-CoV-2 infections in children <16 years in NSW during the study period, of whom 11,985 (68.6%) received care coordinated by SCHN. Twenty one percent of children infected with SARS-CoV-2 were asymptomatic. For every 100 SARS-CoV-2 infections in children <16 years, 1.26 (95% CI 1.06 to 1.46) required hospital admission for medical care; while 2.46 (95% CI 2.18 to 2.73) required admission for social reasons only. Risk factors for hospitalisation for medical care included age <6 months, a history of prematurity, age 12 to <16 years, and a history of medical comorbidities (aOR 7.23 [95% CI 2.92 to 19.4]). Of 17,474 infections, 15 children (median age 12.8years) required ICU admission; and 294 children required hospital admission due to social or welfare reasons.Conclusion The majority of children with SARS-CoV-2 infection (Delta variant) had asymptomatic or mild disease. Hospitalisation was uncommon and occurred most frequently in young infants and adolescents with comorbidities. More children were hospitalised for social reasons than for medical care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPAEDS is funded by the Australian Commonwealth Department of Health to conduct surveillance for childhood COVID-19 and its multi-system inflammatory complications, known as PIMS-TS (also known as MIS-C). In NSW the SCHN childrens hospitals the Childrens Hospital at Westmead and Sydney Childrens Hospital, Randwick are PAEDS sites. Both sites receive additional funding from the NSW Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PAEDS surveillance is approved by the SCHN human research ethics committee (HREC; study number 2019/ETH06144) including a waiver of consent for collection of case data. The aggregate reporting of SCHN virtual care data and NSW wide NCIMS data was approved by the NSW Ministry of Health and SCHN. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors